Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
Chronic kidney disease
2025 Standout
Diabetes-Driven Atherosclerosis: Updated Mechanistic Insights and Novel Therapeutic Strategies
2025 Standout
Works of Markus F. Scheerer being referenced
Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy
2021
Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Markus F. Scheerer | 494 | 278 | 187 | 36 | 671 | |
| J. L. Ruse | 471 | 281 | 182 | 22 | 742 | |
| Aliza Rozenberg | 637 | 262 | 200 | 26 | 719 | |
| Ilan Yanuv | 637 | 261 | 200 | 25 | 718 | |
| Shigehiro Karashima | 526 | 333 | 189 | 69 | 777 | |
| Conn Jw | 328 | 200 | 136 | 28 | 602 | |
| Daniel Lorber | 395 | 158 | 125 | 24 | 765 | |
| Hulda J. Wohltmann | 397 | 211 | 148 | 30 | 755 | |
| Gary K. Yang | 362 | 351 | 149 | 28 | 618 | |
| Cristián A. Amador | 353 | 201 | 127 | 22 | 779 | |
| Lakshini Y. Herat | 397 | 223 | 171 | 34 | 695 |
All Works
Loading papers...